From dopamine 4 to sigma 1: synthesis, SAR and biological characterization of a piperidine scaffold of s1 modulators

08 June 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The sigma 1 receptor is a multifunctional receptor with wide distribution in the nervous system and its function has been implicated with a number of neurological disorders including dementia and Alzheimer’s disease (AD) and other neurodegenerative disorders. In addition, modulators of s1 have been advanced into clinical trials for the treatment of pain. Starting from our previously disclosed piperidine scaffold, we have identified a class of potent sigma 1 modulators. This work highlights the key SAR components that lead to the divergence in D4 and s1 activity. In addition, we further profile lead compounds in panel of off-target receptors, in vitro and in vivo pharmacokinetic studies. This has culminated in the discovery of multiple s1 receptor modulators with properties that will allow for study in animal models.

Keywords

dopamine 4 receptor
sigma 1 receptor
selectivity
modulators
SAR

Supplementary materials

Title
Description
Actions
Title
Experimental conditions and characterization of compounds studied
Description
Included are the synthetic procedures and characterization of the compounds in the manuscript. In addition, pharmacology and selectivity data are included.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.